OsNovum - Bone Regenerative Technology

OsNovum Updates

Below are progress updates and information we’ve disseminated through our newsletter. Feel free to click through the updates and don’t forget to subscribe!

New Methods of Diagnosing Who Will Suffer a Bone Fracture

01 February 2021

The current method of screening for risk of a fragility fracture is a dual-energy X-ray absorptiometry scan commonly referred to as DXA…

Read More

OsNovum Reduces Inflammation and Outperforms the Competition

28 January 2021

The results are in and we are very proud to share the results of our first major FDA study for OsNovum!

Read More

OsNovum Nearing $150K in Funding

19 January 2021

OsNovum has reached a milestone that will allow us to complete our submission and clearance with the FDA…

Read More

Exploring the Financial Future

09 December 2020

When treating a patient, you must put aside any bias or dogma and honestly critique how your patient responds to therapy…

Read More

The Story of OsNovum and a Funding Milestone

24 November 2020

SteinerBio began the research to introduce its technology for the treatment of failing bones due to osteoporosis in 2016…

Read More

Proud Member of:

Tissue Engineering and Regenerative Medicine International Society (TERMIS)
American Society for Bone and Mineral Research (ASBMR)